Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FH-006 in advanced malignant solid tumors
NCT06735144Phase 2Recruiting
- Sponsor
- Hengrui
- Start
- Dec 2024
- Primary completion
- Dec 2027
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of FH-006 in malignant solid tumor, sponsored by Hengrui. Started Dec 2024; status: recruiting.
02
Drugs
FH-006
03
Conditions
malignant solid tumor
Beyond the preview
Go deeper on NCT06735144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06735144.